NYSE - Delayed Quote USD

Stryker Corporation (SYK)

Compare
354.30 +1.01 (+0.29%)
At close: August 26 at 4:00 PM EDT
349.19 -5.11 (-1.44%)
After hours: August 26 at 6:11 PM EDT
Loading Chart for SYK
DELL
  • Previous Close 353.29
  • Open 353.54
  • Bid --
  • Ask --
  • Day's Range 352.92 - 355.86
  • 52 Week Range 249.98 - 361.41
  • Volume 882,692
  • Avg. Volume 1,261,130
  • Market Cap (intraday) 135.015B
  • Beta (5Y Monthly) 0.90
  • PE Ratio (TTM) 39.37
  • EPS (TTM) 9.00
  • Earnings Date Oct 31, 2024 - Nov 4, 2024
  • Forward Dividend & Yield 3.20 (0.91%)
  • Ex-Dividend Date Sep 30, 2024
  • 1y Target Est 378.81

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

www.stryker.com

52,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SYK

View More

Performance Overview: SYK

Trailing total returns as of 8/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SYK
18.86%
S&P 500
17.76%

1-Year Return

SYK
28.69%
S&P 500
27.49%

3-Year Return

SYK
34.85%
S&P 500
24.92%

5-Year Return

SYK
74.89%
S&P 500
97.28%

Compare To: SYK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SYK

View More

Valuation Measures

Annual
As of 8/26/2024
  • Market Cap

    135.02B

  • Enterprise Value

    145.28B

  • Trailing P/E

    39.50

  • Forward P/E

    29.67

  • PEG Ratio (5yr expected)

    2.94

  • Price/Sales (ttm)

    6.37

  • Price/Book (mrq)

    6.83

  • Enterprise Value/Revenue

    6.79

  • Enterprise Value/EBITDA

    27.62

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    16.12%

  • Return on Assets (ttm)

    7.24%

  • Return on Equity (ttm)

    18.58%

  • Revenue (ttm)

    21.39B

  • Net Income Avi to Common (ttm)

    3.45B

  • Diluted EPS (ttm)

    9.00

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.96B

  • Total Debt/Equity (mrq)

    64.49%

  • Levered Free Cash Flow (ttm)

    2.2B

Research Analysis: SYK

View More

Company Insights: SYK

Research Reports: SYK

View More

People Also Watch